Caixin
Five things to know about China's latest IPO system overhaul
Rollout to two biggest boards may trigger a new wave of offerings, analysts say
He Jinbi's Maike imported at a loss, leaving gap others can't fill
Source of counterfeit pills may be Indian generic drug makers, distributors say.
Beijing aims to bolster COVID-hit economy with more public spending
Chinese currency set to gain more traction as PBOC boosts overseas use
Expected to start commercial operation, export in Q1 of 2025.
Cold snap threatens agriculture, water and energy supplies as well as travel
Regulator aims to cull poorly performing companies, violators
China Minsheng Banking Corp. acts as nation's real estate debt piles up
Cyberspace agency also on lookout for displays of ostentatious wealth
Price negotiations with Pfizer break down over more expensive Paxlovid
Analysts forecast raw material and battery supply gluts
In Beijing, Shanghai and Guangzhou, lack of public school capacity now common
Findings show recent credit crunch still hurting confidence in property market
Sector already tops official 2025 target for delivery of new energy vehicles
Overflowing ICUs, lines outside funeral homes will be replicated in other cities
New normal: Brokers find they have to sate different risk appetites
Default risks remain despite government measures, consultant warns
Domestic outbreak could stall airline industry efforts to restaff
Alibaba, Tencent, Didi and Meituan can expect normalized supervision
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.